Early interim data from Trident-1, a registrational Phase 2 of Repotrectinib

Clinical Impact

Aug 19

Written By Frances Benson

2020

Frances Benson

Palleon Pharmaceuticals raises $100M Series B

Principia Biopharma acquired by Sanofi for $3.7BN